Project Grant R21HL175584

Award Date 9/17/24
Completion Date 8/31/26
Dollars Obligated $133K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This federal Project Grant award of $332,862.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, will support research to assess night-to-night variability in novel sleep disordered breathing severity metrics and their impact on daytime functioning. The study aims to characterize reliable biomarkers of obstructive sleep apnea (OSA) severity, as the current standard measure (Apnea-Hypopnea Index) underestimates...
This Project Grant award of $696,470.00 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research at the University of Denver to investigate the relationship between prenatal maternal sleep and offspring cardiovascular disease risk. The research aims to: 1) examine how prenatal maternal sleep trajectories predict maternal biological pathways like inflammation and stress, 2) assess how prenatal maternal sleep impacts offspring growth,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded The Trustees of Columbia University in the City of New York a $821,982 Project Grant under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837). The grant, awarded on July 15, 2024, will fund a 5-year research project to investigate variability in sleep timing as a potential new risk factor for cardiovascular disease (CVD) among women. The study will leverage two racially and ethnically diverse cohorts of women...
This $160,092 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a multisite, longitudinal study to comprehensively evaluate sleep health, sleep disorders, and cognitive functioning in 30 adult heart transplant recipients at Mayo Clinic Arizona. The study aims to: 1) describe sleep health characteristics, sleep disorders, and cognitive function in heart transplant recipients at 6, 9, and 12 months post-transplant; and...
This federal Project Grant award of $752,991 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program supports a comprehensive study to understand the socioecological factors impacting disparities in early childhood sleep health. The project aims to evaluate the effects of understudied risk factors like racism, housing insecurity, screen media use, and toxic stress on child sleep health, as well as assess how socio-cultural,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $594,547 to Harvard Medical School to conduct research on the regulation of arousal and sleep quality. The project aims to characterize a gut-to-brain signaling pathway that uses information about ingested nutrients to control arousal levels and sleep depth, without affecting overall sleep duration. The research will investigate...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $450,000 in funding to Old Dominion University to investigate the relationship between disturbed sleep and the development of vulnerable atherosclerotic plaques. The primary objectives are to: 1) examine the role of NADPH-dependent oxidative stress in accelerating the formation of vulnerable atherosclerotic plaques in...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $667,865 to The Johns Hopkins University to conduct research on the role of microglial glutaminase in HIV-induced sleep deficits. The research aims to: 1) characterize sleep phenotypes in murine models of HIV infection, 2) analyze microglial activation, neuronal activity, neuroinflammation, and microglial transcriptomes in these...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $644,687 to the University of Missouri System to conduct research on a neural circuit in the brain that contributes to hypertension associated with obstructive sleep apnea. The research aims to determine how this "orexin-CRH-NTS" circuit facilitates the peripheral chemoreflex and leads to sympathoexcitation and hypertension,...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,728 to the University of California, San Diego (UCSD) to conduct research on the cardiovascular impacts of comorbid obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), known as overlap syndrome (OVS). The central hypothesis is that poor outcomes in OVS are driven by more pronounced right and left heart...

This Project Grant award of $133,410 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the relationship between sleep quality, sleep apnea, and cardiac aging. The study aims to leverage longitudinal sleep data from the Korean Genome and Epidemiology Study to assess how impaired sleep patterns accelerate cardiovascular disease risk over a 12-year period. The research will focus on determining specific sleep and sleep apnea characteristics that are associated with accelerated cardiac aging. The findings are expected to provide critical insights into leveraging sleep-targeted interventions to preserve cardiac function and prevent deterioration with aging. The award was made on September 17, 2024 with an ultimate completion date of August 31, 2026.

Generated 7/1/25, 4:02 AM